City View Green Holdings Inc. Stock OTC Markets
Stocks
CVGRF
CA1787182015
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
14:35:24 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 0.0307 USD | +3.54% |
|
+3.54% | -58.96% |
| Market Cap | 2.71M 1.95M 1.68M 1.59M 1.44M 187M 2.72M 18.93M 7.28M 94.95M 7.34M 7.18M 300M | P/E 2024 |
-9.02x | P/E 2025 | -2.81x |
|---|---|---|---|---|---|
| Enterprise Value | 2.88M 2.08M 1.79M 1.7M 1.54M 199M 2.9M 20.14M 7.75M 101M 7.81M 7.64M 319M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
84.57% | Yield 2024 * |
-
| Yield 2025 | - |
OTC MarketsUSD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| CVGR | Delayed | |
OTC Markets
| CVGRF | Delayed | |
|
Deutsche Boerse AG
| CVY0 | Delayed |
| 1 day | +3.54% | ||
| 1 week | +3.54% | ||
| Current month | +3.54% | ||
| 1 month | +16.95% | ||
| 3 months | +31.76% | ||
| 6 months | -17.03% | ||
| Current year | -58.96% |
| 1 week | 0.03 |  | 0.03 |
| 1 month | 0.02 | | 0.03 |
| Current year | 0.01 | | 0.18 |
| 1 year | 0.01 | | 0.18 |
| 3 years | 0 | | 0.3 |
| 5 years | 0 | | 0.66 |
| 10 years | 0 | | 1.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Roberto Fia
CEO | Chief Executive Officer | 55 | - |
Sung Min Myung
DFI | Director of Finance/CFO | 40 | 2019-10-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Roberto Fia
BRD | Director/Board Member | 55 | 2014-11-09 |
Andrew Peterson
CHM | Chairman | 78 | - |
Steve Naraine
BRD | Director/Board Member | - | 2023-11-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.54% | +3.54% | - | - | 1.95M | |
| 0.00% | -1.22% | -14.56% | -5.08% | 13.4B | |
| -1.27% | -3.07% | -33.48% | -57.01% | 4.78B | |
| -0.61% | -5.58% | -5.83% | -5.99% | 4.36B | |
| -1.49% | -4.28% | -11.69% | -31.36% | 3.78B | |
| -1.37% | -3.98% | -25.66% | +1.50% | 3.43B | |
| -2.78% | -3.65% | -4.32% | -4.39% | 3.41B | |
| -0.85% | -4.82% | -13.72% | +4.39% | 3.12B | |
| -1.30% | -2.63% | -24.61% | -17.84% | 2.27B | |
| -2.13% | -2.81% | -29.80% | -19.92% | 1.63B | |
| Average | -0.83% | -2.87% | -18.19% | -15.08% | 4.47B | |
| Weighted average by Cap. | -0.94% | -2.27% | -16.80% | -13.80% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -388K -280K -241K -228K -207K -26.73M -390K -2.71M -1.04M -13.6M -1.05M -1.03M -42.97M | -1.06M -767K -661K -626K -567K -73.31M -1.07M -7.43M -2.86M -37.3M -2.88M -2.82M -118M |
| Net Debt | 68.01K 49.03K 42.24K 40K 36.25K 4.68M 68.36K 475K 183K 2.38M 184K 180K 7.53M | 174K 125K 108K 102K 92.71K 11.98M 175K 1.21M 467K 6.09M 471K 461K 19.26M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- CVGR Stock
- CVGRF Stock
Select your edition
All financial news and data tailored to specific country editions
